Vaccine Hesitancy Intervention--Provider (VHIP)

Childhood Vaccination Clinical Trial

— VHIP  

Official title:

Vaccine Hesitancy Intervention--Provider (VHIP)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01667354
• Other study ID #: 250147
• Status: Completed
• Phase: N/A
• First received: March 6, 2012
• Last updated: October 11, 2017
• Start date: February 2012
• Est. completion date: April 2014

Study information

• Verified date: October 2017
• Source: Kaiser Permanente
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary aim of this trial is to test the effectiveness of an intervention to train primary care physicians to determine if it leads to decreased parental vaccine hesitancy.

Description:

The primary aim of this trial is to test the effectiveness of an intervention to train primary care physicians to determine if it leads to decreased parental vaccine hesitancy. The investigators will train primary care teams with an initial training followed by telephone coaching and follow-up visits, and assess the outcomes of parental vaccine hesitancy (primary) and physician self-efficacy (secondary) at baseline and 6 months.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 491
• Est. completion date: April 2014
• Est. primary completion date: October 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Study population:

• Eligible pediatric and family medicine practices in three counties in Washington State; King, Pierce and Snohomish Counties.

• Mothers whose infants will receive care in participating clinics.

Inclusion Clinics:

• Located in King, Snohomish, Pierce Counties, WA;

• Family practice clinics;

• Pediatric practice clinics;

• Order > 1000 doses of vaccine in 2009 from State of Washington Department of Health.

Exclusion Clinics: Not willing to be randomized.

Inclusion Mothers:

• Babies born at participating hospitals;

• Mother can be recruited before discharged post-birth;

• Mothers declare pediatric care at one of participating clinics;

• Singleton or twin pregnancies.

Exclusion Mothers:

• Babies born < 36 weeks gestational age;

• Known medical vaccine contraindications;

• Parental age < 18;

• NICU;

• Triplet or more;

• Maternal complications.

Related Conditions & MeSH terms

• Childhood Vaccination

Intervention

Behavioral:
• Academic Detailing
The intervention design is based on "academic detailing," an effective method of changing physician behavior. The aim of the training is effective communication with parents who are hesitant about childhood vaccinations.

Locations

Country	Name	City	State
United States	Group Health Research Institute	Seattle	Washington

Sponsors (4)

Lead Sponsor	Collaborator
Kaiser Permanente	Seattle Children's Hospital, Washington State, Department of Health, WithinReach

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Parental Vaccine Hesitancy Measure	The investigators will contact mothers of newborns in study practices and conduct a telephone survey at two time points: baseline and 6 months. Surveys will assess parental hesitancy, parental trust in provider, and other covariates such as perceived social norms, other sources of information about vaccines, and demographic information.	Change from Baseline in Parental Hesitancy at 6 months
Secondary	Physician Self Efficacy Measure	Assessed via self-administered surveys of providers in all participating clinics at baseline and 6-months. The investigators will measure physician attitudes, perceived norms, intentions to change behavior, practice characteristics, and physician demographics.	Change from Baseline in Physician Attitudes at 6 months